Infectious Keratitis Treated With Corneal Crosslinking

被引:122
作者
Makdoumi, Karim [1 ]
Mortensen, Jes [1 ]
Crafoord, Sven [1 ]
机构
[1] Orebro Univ Hosp, Dept Ophthalmol, SE-70185 Orebro, Sweden
关键词
CXL; crosslinking; riboflavin; keratitis; UV-A; ultraviolet A; corneal melting; IN-SITU KERATOMILEUSIS; RESISTANT BACTERIAL KERATITIS; PATHOGEN-REDUCTION; ULTRAVIOLET-LIGHT; MIRASOL PRT; RIBOFLAVIN; INACTIVATION; COLLAGEN; KERATOCONUS; PLASMA;
D O I
10.1097/ICO.0b013e3181d2de91
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To describe 7 eyes with severe infectious keratitis treated using collagen crosslinking (CXL) with riboflavin. Materials and Methods: Seven eyes of 6 patients with severe infectious keratitis were treated with corneal crosslinking. Three patients were contact lens users. Symptom duration before CXL ranged between 0 and 7 days. Corneal melting was present in all cases. Photodocumentation of the keratitis was carried out and repeated at follow-up. All but 1 patient received topical antibiotic treatment in addition to the CXL treatment. CXL was conducted according to the standardized protocol for keratoconus. Results: In all but 1 eye, patients experienced improvement in symptoms within 24 hours. Two patients reported no symptoms whatsoever at this time. Corneal melting was arrested and complete epithelialization was achieved in all cases. In the 2 eyes with hypopyon, this regressed completely within 2 days after the CXL. Follow-up ranged between 1 and 6 months. Discussion: Our experience based on the above and other cases suggest that CXL could be an effective tool in battling difficult cases of infectious keratitis. This treatment could present many advantages but will need further investigation.
引用
收藏
页码:1353 / 1358
页数:6
相关论文
共 35 条
[1]   Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction [J].
AuBuchon, JP ;
Herschel, L ;
Roger, J ;
Taylor, H ;
Whitley, P ;
Li, JZ ;
Edrich, R ;
Goodrich, RP .
TRANSFUSION, 2005, 45 (08) :1335-1341
[2]   Characterization of the antinociceptive and anti-inflammatory activities of riboflavin in different experimental models [J].
Bertollo, Caryne M. ;
Oliveira, Antonio Carlos P. ;
Rocha, Leonardo Tadeu S. ;
Costa, Karina A. ;
Nascimento, Elias B., Jr. ;
Coelho, Marcio M. .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 547 (1-3) :184-191
[3]   Parasurgical therapy for keratoconus by rib oflavin-ultraviolet type A rays induced cross-linking of corneal collagen - Preliminary refractive results in an Italian study [J].
Caporossi, A ;
Baiocchi, S ;
Mazzotta, C ;
Traversi, C ;
Caporossi, T .
JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2006, 32 (05) :837-845
[4]   Pathogen inactivation of Trypanosoma cruzi in plasma and platelet concentrates using riboflavin and ultraviolet light [J].
Cardo, Lisa J. ;
Salata, Jeanne ;
Mendez, Juan ;
Reddy, Heather ;
Goodrich, Raymond .
TRANSFUSION AND APHERESIS SCIENCE, 2007, 37 (02) :131-137
[5]   Pathogen inactivation of Leishmania donovani infantum in plasma and platelet concentrates using riboflavin and ultraviolet light [J].
Cardo, LJ ;
Rentas, FJ ;
Ketchum, L ;
Salata, J ;
Harman, R ;
Melvin, W ;
Weina, PJ ;
Mendez, J ;
Reddy, H ;
Goodrich, R .
VOX SANGUINIS, 2006, 90 (02) :85-91
[7]   Atypical mycobacteria keratitis after laser in situ keratomileusis unresponsive to fourth-generation fluoroquinolone therapy [J].
de la Cruz, Jose ;
Behlau, Irmgard ;
Pineda, Roberto .
JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2007, 33 (07) :1318-1321
[8]   The Mirasol TM PRT system for pathogen reduction of platelets and plasma:: An overview of current status and future trends [J].
Goodrich, Raymond P. ;
Edrich, Richard A. ;
Li, Junzhi ;
Seghatchian, Jerard .
TRANSFUSION AND APHERESIS SCIENCE, 2006, 35 (01) :5-17
[9]  
Goodrich RP, 2000, VOX SANG, V78, P211
[10]   A longitudinal study of trends in keratitis in Australia [J].
Green, Matthew ;
Apel, Andrew ;
Stapleton, Fiona .
CORNEA, 2008, 27 (01) :33-39